The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quality-of-life (QOL) analyses in patients with multiple myeloma: Results from the selinexor (KPT-330) treatment of refractory myeloma (STORM) phase IIb study.
 
Sundar Jagannath
Honoraria - Celgene; Karyopharm Therapeutics
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Novartis
Research Funding - Bristol-Myers Squibb (Inst); celgene (Inst); Karyopharm Therapeutics (Inst)
 
jyotsna mehta
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
Research Funding - Karyopharm Therapeutics (Inst)
 
Janis Breeze
Employment - Purple Squirrel Economics
 
Gabriel Tremblay
Employment - Purple Squirrel Economics
Leadership - Purple Squirrel Economics
Stock and Other Ownership Interests - Purple Squirrel Economics
Consulting or Advisory Role - Karyopharm Therapeutics (Inst)
 
Lingling Li
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
Research Funding - Karyopharm Therapeutics
 
Noa Biran
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Takeda
Consulting or Advisory Role - Amgen; Celgene; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Karyopharm Therapeutics (Inst); Merck (Inst)
 
Sharon Shacham
Employment - Karyopharm Therapeutics
Leadership - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
Research Funding - Karyopharm Therapeutics
 
Michael G. Kauffman
Employment - Karyopharm Therapeutics
Leadership - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
Research Funding - Karyopharm Therapeutics
 
Jatin J. Shah
Employment - Karyopharm Therapeutics
Leadership - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
Research Funding - Karyopharm Therapeutics (Inst)